GOUT

This study tests whether regular email check-ups can help people with gout reach and maintain safe urate levels, potentially curing the disease. About 204 adults with gout will either receive standard care or email-guided treatment adjustments. The goal is to see if this approach…

This study tests a new oral medication, AR882, taken with a standard gout drug (XOI) in 15 adults with uncontrolled gout who could not tolerate or stopped responding to uricase infusions. The goal is to lower uric acid levels below 6 mg/dL and shrink painful uric acid crystal dep…

This study tests a smartphone chatbot called Gout Buddy that gives personalized diet advice to people with gout. About 110 adults will either use the chatbot or get standard care for 3-6 months. Researchers will check if the chatbot helps improve diet knowledge, eating habits, an…

This study tests a new medicine called AR882 in 750 adults with gout. The goal is to see if it can lower uric acid levels and reduce painful gout flares over 12 months. Participants receive either AR882 or a placebo. This is a phase 3 trial, meaning it is one of the final steps b…

This study helps 200 adults with gout, especially African Americans in the Southeast, get better care through an emergency department program. It focuses on improving treatment for flare-ups and long-term management. The study also aims to increase minority involvement in medical…

This study tests whether anakinra works better than prednisone for treating gout flares in people with advanced chronic kidney disease or who have had a kidney transplant. Gout causes sudden, painful joint inflammation, and standard treatments like colchicine and NSAIDs are not s…

This study is a review of many smaller trials that looked at what happens when people replace animal proteins (like meat, dairy, eggs) with plant proteins (like beans, nuts, seeds). The goal is to see if this simple swap can improve blood sugar, cholesterol, blood pressure, weigh…